[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM

[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM

中文名称[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM
中文同义词[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM;1,2,4]三唑并[1,5-A]嘧啶-4(7H)-乙酰胺,N-[2-氯-4-(三氟甲基)苯基]-2-(3,6-二氢-2H-吡喃-4-基)-5-乙基-6-[4-[(5-羟基-6-甲基-4-吡喃;N-(2-氯-4-(三氟甲基)苯基)-2-(2-(3,6-二氢-2H-吡喃-4-基)-5-乙基-6-(4-(5-羟基-6-甲基嘧啶-4-羰基)哌嗪-1-基)-7-氧代-[1,2,4]三唑并[1,5-A]嘧啶-4(7H)-基)乙酰胺;[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYR;WERNER 综合征 RECQ 解旋酶-IN-1,10 MM DMSO 溶液;WERNER 综合征 RECQ 解旋酶-IN-1
英文名称[1,2,4]Triazolo[1,5-a]pyrimidine-4(7H)-acetamide, N-[2-chloro-4-(trifluoromethyl)phenyl]-2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-[4-[(5-hydroxy-6-methyl-4-pyrimidinyl)carbonyl]-1-piperazinyl]-7-oxo-
英文同义词[1,2,4]Triazolo[1,5-a]pyrimidine-4(7H)-acetamide, N-[2-chloro-4-(trifluoromethyl)phenyl]-2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-[4-[(5-hydroxy-6-methyl-4-pyrimidinyl)carbonyl]-1-piperazinyl]-7-oxo-;Werner syndrome RecQ helicase-IN-1;N-(2-chloro-4-(trifluoromethyl)phenyl)-2-(2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-(4-(5-hydroxy-6-methylpyrimidine-4-carbonyl)piperazin-1-yl)-7-oxo-[1,2,4]triazolo[1,5-a]pyrimidin-4(7H)-yl)acetamide;Werner syndrome RecQ helicase-IN-1, 10 mM in DMSO;N-(2-chloro-4-(trifluoromethyl)phenyl)-2-(2-(3,6-dihydro-2H-pyran-4-yl)-5-ethyl-6-(4-(5-hydroxy-6-methylpyrimidine-4-carbonyl)azine-1-yl)-7-oxy-[1,2,4]triazolebenzo[1,5-a]pyrimidine-4(7H)-yl)acetamide;RHO761;Werner syndrome RecQ helicase-IN-1 HRO761
CAS号2869954-34-5
分子式C31H31ClF3N9O5
分子量702.08
EINECS号
相关类别
Mol文件2869954-34-5.mol
结构式[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM 结构式

[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM 性质

密度1.58±0.1 g/cm3(Predicted)
溶解度DMSO: Slightly soluble: 0.1-1 mg/ml
酸度系数(pKa)5.87±0.45(Predicted)
形态固体
颜色白色至浅黄色
InChIKeyXKYVECRUZPCRQR-UHFFFAOYSA-N
SMILESC12=NC(C3=CCOCC3)=NN1C(=O)C(N1CCN(C(C3C(O)=C(C)N=CN=3)=O)CC1)=C(CC)N2CC(NC1=CC=C(C(F)(F)F)C=C1Cl)=O

[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM 用途与合成方法

HRO761 (Werner syndrome RecQ helicase-IN-1) (example 42)是一种有效的 Werne r综合征 RecQ DNA 解旋酶 (WRN) 抑制剂,可用于癌症研究。

安全信息

MSDS信息

更新日期产品编号产品名称CAS号包装价格
2026/09/15HY-148699Werner syndrome RecQ helicase-IN-15 mg1000元
2026/09/15HY-148699Werner syndrome RecQ helicase-IN-110 mg1450元

[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM 上下游产品信息

"[1,2,4]TRIAZOLO[1,5-A]PYRIMIDINE-4(7H)-ACETAMIDE, N-[2-CHLORO-4-(TRIFLUOROMETHYL)PHENYL]-2-(3,6-DIHYDRO-2H-PYRAN-4-YL)-5-ETHYL-6-[4-[(5-HYDROXY-6-METHYL-4-PYRIM"相关产品信息
1002789-86-7 (3E,5E)-3,5-双(4-硝基亚苄基)哌啶-4-酮 PCNA-I1 化合物WERNERSYNDROMERECQHELICASE-IN-2 化合物WERNERSYNDROMERECQHELICASE-IN-4 布喹那
主页 | 企业会员服务 | 广告业务 | 联系我们 | 旧版入口 | 中文MSDS | CAS Index | 常用化学品CAS列表 | 化工产品目录 | 新产品列表 | 评选活动 | HS海关编码 | MSDS查询 | 化工站点

Copyright © 2016-2023 ChemicalBook 版权所有  京ICP备07040585号  京公海网安备11010802032676号  

互联网增值电信业务经营许可证:京ICP证150597号  (京)网药械信息备字(2025)第00154号  信息系统安全等级保护备案证明(三级)  营业执照公示

本网站展示的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用。
根据相关法律法规和本站规定,单位或个人购买相关危险物品应取得有效的资质、资格条件。

参考《应急管理部等多部门关于加强互联网销售危险化学品安全管理的通知 (应急〔2022〕119号)》《互联网危险物品信息发布管理规定》